Watchlist
Loading...
US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist
0.0715 -0.0121-14.47% Trading 11/30 12:33 ET
0.0850High0.0612Low28.72MVolume
Intraday
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About Avalo Therapeutics Company

Avalo Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of treatments for rare and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.

Revenue Breakdown

Business Currency:USD
2022/12/31
Stock NameRevenueRatio
License revenue14.69M81.36%
Product revenue, net3.36M18.64%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >